Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for <i>Pseudomonas aeruginosa</i> Infections
Outpatient treatment of <i>Pseudomonas aeruginosa</i> infections is challenged by increasing rates of resistance to fluoroquinolones, the only class of antibiotics which offers an established oral route of administration against this organism. Azithromycin does not demonstrate activity a...
Saved in:
Main Authors: | Erlinda R. Ulloa (Author), George Sakoulas (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indazole-Quinolone Hybrids as Anti-Virulence Agents against <i>Pseudomonas aeruginosa</i>
by: Marie Hanot, et al.
Published: (2024) -
Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020) -
In vitro exposure of chlorhexidine induce quinolone resistance in Pseudomonas aeruginosa
by: M. Kawamura, et al.
Published: (2020) -
<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021) -
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021)